New Study Suggests Link Between Improved Biological Age Gap and Reduced Stroke Risk
A preliminary study, slated for presentation at the American Academy of Neurology's 78th Annual Meeting in April 2026, has uncovered a significant association. It indicates that improving the gap between biological and chronological age correlates with a reduced risk of stroke and fewer indicators of brain damage.
Study Design
Researchers embarked on an extensive analysis, examining the biological age of 258,169 individuals sourced from a comprehensive health care research database. Biological age was meticulously determined using a panel of 18 distinct blood biomarkers, which included crucial indicators such as cholesterol levels and white blood cell count.
Initial measurements were recorded at the commencement of the study. For a select subset of participants, these assessments were repeated six years later. The entire cohort was then observed for an average duration of 10 years, specifically to identify the occurrence of stroke. Additionally, a smaller subset underwent specialized memory and thinking skill tests, complemented by brain scans designed to detect early signs of damage.
Key Findings
At the study's outset, participants presented with an average biological age of 54, while their average chronological age was 56. Six years later, their biological age averaged 58, in contrast to an average chronological age of 62.
Individuals whose biological age surpassed their chronological age showed concerning trends. By the study's conclusion, these participants exhibited less favorable brain scans and registered lower scores on cognitive tests. Crucially, they also faced a 41% higher risk of stroke.
Participants who demonstrated an improvement in the gap between their biological and chronological ages between the initial and repeat assessments were 23% less likely to experience a stroke during the follow-up period.
Furthermore, those who achieved improvements in their age gap also displayed healthier brain indicators. They presented with a lower volume of white matter hyperintensities – a significant marker for damaged white matter tissue – by the study's end. For each standard deviation of improvement in the age gap, their total volume of damage was 13% lower.
It is important to note that these compelling results remained significant after accounting for other influential factors. These included high blood pressure, other known vascular conditions, and various socioeconomic factors that could impact the risk of stroke and brain damage.
Limitations and Future Research
Dr. Cyprien Rivier, MD, MSc, of Yale University, a lead author of the study, emphasized the need for further investigation.
"More research is needed to determine if reducing people's biological age gap can be proven to lower the risk of stroke and later-life brain injury," stated Dr. Rivier.
A key limitation of this preliminary study is its design, which identified associations but was not engineered to establish a direct cause-and-effect relationship. Moreover, conclusions regarding changes over time, especially concerning cognitive tests, are somewhat restricted due to the smaller group that received repeat blood tests.